Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Servier
Deal Size : $262.2 million
Deal Type : Collaboration
Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
Details : As part of the collaboration, MiNA Therapeutics will use its saRNA platform to identify new potential treatments to restore normal cell function in neurological disorders.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
January 21, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Servier
Deal Size : $262.2 million
Deal Type : Collaboration